Stubborn cancer cells play a cunning trick when faced with treatments designed to kill them—they eat themselves to survive. But Lisa Schafranek has found a way to starve the cancer cells, making them more susceptible to cancer therapy.
Lisa and her team at the South Australian Health and Medical Research Institute have used a clinically available drug, originally developed as an antibiotic to treat lung infections, to stop leukaemia cells from eating themselves to survive cancer therapy.